IMBA Group Leader Nicolas Rivron has received an Honorable Mention as a finalist for the 2026 ISSCR Early Career Impact Award, in recognition of his pioneering work on stem cell-based embryo models of mouse and human development and his leadership in…

Anna Osnato and Mark Noble, postdocs at IMBA in the laboratories of Nicolas Rivron and Jürgen Knoblich, respectively, were awarded prestigious Marie Skłodowska-Curie Postdoctoral Fellowships.

Axolotls can regrow both limbs and tails, and scientists assumed that this was done through the same cells and strategies. By showing that muscle stem cells in the tail act differently from muscle stem cells in the limbs, scientists around Ji-Feng…

Sven Klumpe, joint Group Leader at IMBA and the Research Institute of Molecular Pathology (IMP), has received a new international grant from the Chan Zuckerberg Initiative’s Biohub in collaboration with Monash University.

Kalki Kukreja, postdoc at IMBA, has been awarded an APART-USA Fellowship by the Austrian Academy of Sciences (ÖAW). She is the first APART-USA scholar at IMBA and joins the institute through this highly competitive fellowship.

Olena Kim, postdoc in Jürgen Knoblich’s lab at IMBA, has received an APART-MINT Fellowship to study the neurodevelopmental defects causing tuberous sclerosis, a rare genetic type of childhood epilepsy.

Computational biologist Daan de Groot, currently a postdoctoral researcher at the Biozentrum in Basel, Switzerland, will join IMBA as group leader in June of 2026. The de Groot lab will study how cells define their fate during embryonic development—a…

A new ERC Proof of Concept Grant will support IMBA Group Leader Nicolas Rivron in translating human blastoid technology toward applications in fertility research and reproductive medicine.

When DNA breaks, cells face a daunting challenge: finding the exact matching sequence needed for accurate repair within a genome folded into a dense three-dimensional maze. Researchers in the lab of Daniel Gerlich at IMBA have now discovered how the…

IMBA scientists have joined forces with three other organizations in an initiative to accelerate research and potential treatment options for Coffin-Siris syndrome, a rare genetic disorder caused by ARID1B haploinsufficiency that results in severe…